Carcinoma in situ of skin, unspecified
ICD-10 D04.9 is a billable code used to indicate a diagnosis of carcinoma in situ of skin, unspecified.
Carcinoma in situ of the skin is a non-invasive form of skin cancer characterized by the presence of abnormal cells that have not yet invaded deeper layers of the skin. This condition is often detected during routine skin examinations or biopsies. The term 'unspecified' indicates that the exact location or type of carcinoma in situ has not been clearly defined. Common types of carcinoma in situ include squamous cell carcinoma in situ (SCCIS) and basal cell carcinoma in situ (BCCIS). While these lesions are not life-threatening, they can progress to invasive cancer if left untreated. Regular surveillance and monitoring are crucial for early detection and intervention. Treatment options may include surgical excision, cryotherapy, or topical chemotherapy, depending on the lesion's characteristics and patient factors. The prognosis for carcinoma in situ is generally favorable, with a high cure rate when appropriately managed.
Detailed descriptions of the lesion, including size, location, and histological findings.
Diagnosis during skin checks, biopsy results indicating carcinoma in situ, and treatment planning.
Ensure clear documentation of the type of carcinoma in situ and any treatment recommendations.
Comprehensive treatment plans, including follow-up care and surveillance protocols.
Management of patients with a history of skin cancer and surveillance for recurrence.
Document any multidisciplinary approaches to treatment and patient education efforts.
Used when excising a carcinoma in situ lesion.
Pathology report confirming carcinoma in situ and details of the excised lesion.
Dermatologists should ensure clear documentation of the lesion's characteristics.
Carcinoma in situ is significant because it represents an early stage of cancer that has not invaded surrounding tissues. Early detection and treatment can prevent progression to invasive cancer.
